Get your full text copy in PDF
Niamh A. Keane, Louise Marie Lane, Emma Canniff, Daniel Hare, Simon Doran, Eugene Wallace, Siobhan Hutchinson, Marie-Louise Healy, Brian Hennessy, Jim Meaney, Peter Chiodini, Brian O’Connell, Alan Beausang, Elisabeth Vandenberghe
(Department of Hematology, St. James’s Hospital, Dublin, Ireland)
Am J Case Rep 2020; 21:e923219
Acanthamoeba are free-living amoebae with potential to infect immunocompromised hosts. The mortality rate of granulomatous amebic encephalitis (GAE) due to Acanthamoeba exceeds 90% and there are currently no reports of survival of this infection in recipients of hematopoietic stem cell transplant.
CASE REPORT: We report herein the case of a 32-year-old man presenting to our service with abrupt neurological deterioration and seizures 5 months after allogeneic stem cell transplantation for Hodgkin lymphoma. Clinical and imaging findings were non-specific at presentation. Multiple circumscribed, heterogenous, mass-like lesions were identified on MRI. Brain biopsy was performed and revealed multiple cysts and trophozoites suggesting a diagnosis of granulomatous amebic encephalitis. PCR testing confirmed Acanthamoeba. Treatment with miltefosine, metronidazole, azithromycin, fluconazole, pentamidine isethionate, and co-trimoxazole was instituted and the patient survived and shows continued improvement with intensive rehabilitation.
CONCLUSIONS: We report the first successful outcome in this setting. The diagnosis would have been missed on cerebrospinal fluid analysis alone, but was rapidly made by histological analysis of brain biopsy. This diagnostically challenging infection is likely under-recognized. Early brain biopsy and commencement of a prolonged miltefosine-containing anti-ameba regimen can be curative.
Keywords: Acanthamoeba, Amoeba, Central Nervous System Protozoal Infections, Hematopoietic Stem Cell Transplantation